Carregant...
Determination of maximum tolerated dose and toxicity of Inauhzin in mice
Reactivating the tumor suppressor p53 offers an attractive strategy for developing cancer therapy. We recently identified Inauhzin (INZ) as a novel non-genotoxic p53-activating compound. To develop INZ into a clinically applicable anticancer drug, we have initiated preclinical toxicity studies. Here...
Guardat en:
| Publicat a: | Toxicol Rep |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Elsevier
2015
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4497815/ https://ncbi.nlm.nih.gov/pubmed/26167454 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.toxrep.2015.02.011 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|